NCT06110884 Music Therapy for Speech and Prosody in Autistic Children (MTSPAC)
| NCT ID | NCT06110884 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Taiwan University Hospital |
| Condition | Autism |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2024-01-17 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2024-01-17 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This research is a single-blind randomized controlled trial, where the investigators plan to recruit 40 children with autism, randomly divided into two groups. The music therapy intervention group will receive an hour of group music therapy in addition to traditional language therapy. The control group will receive only traditional language therapy. The trial will last for 8 weeks, and participants in both groups will be assessed before and after the trial. During the study, the investigators will use professional recording equipment to record their speech and use the speech analysis software to objectively compare whether there are significant differences in prosody between the two groups of children with autism before and after the intervention. Besides the acoustic measurement the investigators also assess the language abilities autism trait performance, adaptive function, emotional behavior, and parent-child stress levels.
Eligibility Criteria
Inclusion Criteria: * children with autism * aged 3-5 y/o * children with speech delay (T-score of Preschool Language Scale \< 40) * Mandarin as first language Exclusion Criteria: * children with other neurological diseases * children without verbal output * children with articulation or voice disorder
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06110884 clinical trial?
This trial is open to participants of all sexes, aged 3 Years or older, up to 5 Years, studying Autism. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06110884 currently recruiting?
Yes, NCT06110884 is actively recruiting participants. Contact the research team at G03486@hch.gov.tw for enrollment information.
Where is the NCT06110884 trial being conducted?
This trial is being conducted at Hsinchu, Taiwan.
Who is sponsoring the NCT06110884 clinical trial?
NCT06110884 is sponsored by National Taiwan University Hospital. The trial plans to enroll 40 participants.